Citicoline, use in cognitive decline: Vascular and degenerative

Journal of the Neurological Sciences

Volumn 299, Issue 1-2, 2010, Pages 188-192

  García Cobos, Rocío ^a   Frank García, Ana ^a   Gutiérrez Fernández, María ^a   Díez Tejedor, Exuperio ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Animal models; Citicoline; Clinical trials; Cognitive impairment; Dementia; Stroke

Indexed keywords

CITICOLINE;

ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; HISTOLOGY; HUMAN; IRRITABILITY; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RESTLESSNESS; REVIEW; SIDE EFFECT;

EID: 78649511776     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.08.027     Document Type: Article

References (49)

1. R.M. Adibhatla, J.F. Hatcher, and R.J. Dempsey Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia Stroke 32 10 2001 2376 2381
2. R.M. Adibhatla, J.F. Hatcher, and R.J. Dempsey Citicoline: neuroprotective mechanisms in cerebral ischemia J Neurochem 80 1 2002 12 23
3. R.V. Dorman, Z. Dabrowiecki, and L.A. Horrocks Effects of CDPcholine and CDPethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia J Neurochem 40 1 1983 276 279
4. A.M. Rao, J.F. Hatcher, and R.J. Dempsey Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection J Neurochem 75 6 2000 2528 2535
5. M. Rigoulet, B. Guerin, F. Cohadon, and M. Vandendreissche Unilateral brain injury in the rabbit: reversible and irreversible damage of the membranal ATPases J Neurochem 32 2 1979 535 541
6. C. Plataras, S. Tsakiris, and P. Angelogianni Effect of CDP-choline on brain acetylcholinesterase and Na(+), K(+)-ATPase in adult rats Clin Biochem 33 5 2000 351 357
7. X.A. Alvarez, C. Sampedro, R. Lozano, and R. Cacabelos Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats Methods Find Exp Clin Pharmacol 21 8 1999 535 540
8. J. Krupinski, I. Ferrer, M. Barrachina, J.J. Secades, J. Mercadal, and R. Lozano CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat Neuropharmacology 42 6 2002 846 854
9. S.M. Babb, L.L. Wald, B.M. Cohen, R.A. Villafuerte, S.A. Gruber, and D.A. Yurgelun-Todd Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study Psychopharmacology (Berl) 161 3 2002 248 254
10. J.L. Saver Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair Rev Neurol Dis 5 4 2008 167 177
11. J.J. Secades, and J.L. Lorenzo Citicoline: pharmacological and clinical review, 2006 update Methods Find Exp Clin Pharmacol 28 Suppl B 2006 1 56
12. M. Kakihana, N. Fukuda, M. Suno, and A. Nagaoka Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia Stroke 19 2 1988 217 222
13. W.R. Schäbitz, J. Weber, K. Takano, B.W. Sandage, K.W. Locke, and M. Fisher The effects of prolonged treatment with citicoline in temporary experimental focal ischemia J Neurol Sci 138 1-2 1996 21 25
14. W.R. Schäbitz, F. Li, K. Irie, B.W. Sandage Jr., K.W. Locke, and M. Fisher Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia Stroke 30 2 1999 427 431 discussion 431-2
15. M. Alonso de Leciñana, M. Gutiérrez, J.M. Roda, F. Carceller, and E. Díez-Tejedor Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke J Neurol Sci 247 2 2006 121 129
16. M. Gutiérrez, E. Díez-Tejedor, M. Alonso de Leciñana, B. Fuentes, F. Carceller, and J.M. Roda Thrombolysis and neuroprotection in cerebral ischemia Cerebrovasc Dis 21 Suppl 2 2006 118 126
17. Álvarez-Sabín J., Díez-Tejedor E., Gutiérrez M.Citicolina en el tratamiento del infarto cerebral agudo. Tratamiento del ictus isquémico. Marge Medica Books, Barcelona, 2009. ISBN: 978-84-92442-13-3.
18. A. Shuaib, Y. Yang, and Q. Li Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: neuroprotective effects when used alone or in combination with urokinase Exp Neurol 161 2 2000 733 739
19. O. Hurtado, A. Cárdenas, J.M. Pradillo, J.R. Morales, F. Ortego, and T. Sobrino A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke Neurobiol Dis 26 1 2007 105 111
20. J.D. Rothstein, M. Dykes-Hoberg, C.A. Pardo, L.A. Bristol, L. Jin, and R.W. Kuncl Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate Neuron 16 3 1996 675 686
21. S. Li, M. Mallory, M. Alford, S. Tanaka, and E. Masliah Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression J Neuropathol Exp Neurol 56 8 1997 901 911
22. D.V. Dabir, M.B. Robinson, E. Swanson, B. Zhang, J.Q. Trojanowski, and V.M. Lee Impaired glutamate transport in a mouse model of tau pathology in astrocytes J Neurosci 26 2 2006 644 654
23. S.A. Lipton, and P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N Engl J Med 330 9 1994 613 622
24. J.D. Rothstein, M. Van Kammen, A.I. Levey, L.J. Martin, and R.W. Kuncl Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis Ann Neurol 38 1 1995 73 84
25. C.L. Lin, L.A. Bristol, L. Jin, M. Dykes-Hoberg, T. Crawford, and L. Clawson Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis Neuron 20 3 1998 589 602
26. ICTUS Study: International Citicoline Trial on acUte Stroke (NCT00331890). Last update on June 9, 2010. http://www.thelancet.com/journals/ lancet/misc/protocol/06PRT-3005.
27. A. Dávalos, J. Castillo, J. Alvarez-Sabín, J.J. Secades, J. Mercadal, and S. López Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials Stroke 33 12 2002 2850 2857
28. J.T. O'Brien, T. Erkinjuntti, B. Reisberg, G. Roman, T. Sawada, and L. Pantoni Vascular cognitive impairment Lancet Neurol 2 2 2003 89 98
29. G.C. Roman Cholinergic dysfunction in vascular dementia Curr Psychiatry Rep 7 1 2005 18 26
30. R.D. Pratt, and C.A. Perdomo Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits Ann NY Acad Sci 977 2002 513 522
31. G.C. Román, D.G. Wilkinson, R.S. Doody, S.E. Black, S.P. Salloway, and R.J. Schindler Donepezil in vascular dementia: combined analysis of two large-scale clinical trials Dement Geriatr Cogn Disord 20 6 2005 338 344
32. D. Craig, and J. Birks Galantamine for vascular cognitive impairment Cochrane Database Syst Rev 1 2006 CD004746
33. A.F. Kurz, T. Erkinjuntti, G.W. Small, S. Lilienfeld, and C.R. Damaraju Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease Eur J Neurol 10 6 2003 633 640 (Pubitemid 38030872)
34. R. Moretti, P. Torre, R.M. Antonello, G. Cazzato, S. Griggio, and M. Ukmar Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study Int J Clin Pract 58 4 2004 346 353
35. D. Craig, and J. Birks Rivastigmine for vascular cognitive impairment Cochrane Database Syst Rev 2 2005 CD004744
36. J.M. Orgogozo, A.S. Rigaud, A. Stöffler, H.J. Möbius, and F. Forette Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300) Stroke 33 7 2002 1834 1839
37. M. Fioravanti, and M. Yanagi Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly Cochrane Database Syst Rev 2 2005 CD000269
38. T. Erkinjuntti Clinical criteria for vascular dementia: the NINDS-AIREN criteria Dementia 5 3-4 1994 189 192
39. R. Cohen, J. Browndyke, D. Moser, and R. Paul Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes Cerebrovasc Dis 16 2003 199 204
40. F. Amenta, L. Parnetti, V. Gallai, and A. Wallin Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? Mech Ageing Dev 122 16 2001 2025 2040
41. L. Parnetti, F. Mignini, D. Tomassoni, E. Traini, and F. Amenta Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? J Neurol Sci 257 1-2 2007 264 269
42. M. De Jesus Moreno Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial Clin Ther 25 2003 178 193
43. S.L. Rogers, and L.T. Friedhoff the Donepezil Study Group. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US muhicentre, randomized, double-blind, placebo-controlled trial Dementia 7 1996 293 303
44. S.L. Rogers, M.R. Farlow, R.S. Doody, R. Mohs, and L.T. Friedhoff A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease Neurology 50 1998 136 145
45. S.L. Rogers, R.S. Doody, R.C. Mohs, and L.T. Friedhoff for the Donepezil Study Group. Donepezil improves cognition and global function in Alzheimer disease, a 15-week, double-blind, placebo-controlled study Arch Intern Med 158 1998 1021 1031
46. A. Burns, M. Rossor, J. Hecker, S. Gauthier, H. Petit, and H.J. Moller The effects of donepezil in Alzheimer's disease-results from a multinational trial Dement Geriatr Cogn Disord 10 1999 237 244
47. K. Narasimhalu, S. Ang, D.A. De Silva, M.C. Wong, H.M. Chang, and K.S. Chia Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort Neurology 73 2009 1866 1872
48. X.A. Alvarez, R. Mouzo, V. Pichel, P. Pérez, M. Laredo, and L. Fernández-Novoa Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion Methods Find Exp Clin Pharmacol 21 9 1999 633 644
49. F. Pujadas, M. Olabarrieta, and J. Álvarez Sabín Tratamiento del deterioro cognitivo de tipo vascular. Deterioro cognitivo de tipo vascular Ergon 2009 978-84-8473-753-7 251 252 4° Congreso Portugues do AVC